49VOL 28, NO.1 - JUNE 2012

REFERENCES: 1 Courteheuse C.

R e c i p r o c a l r e s p o n s i b i l i t y : t h e c a s e wit h a s t h m a . [Fr e n c h] Revue Medicale de la Suisse Romande, 1992, 112:235-238.

2 WH O : Wo r l d he a l t h or g a n i z a t i o n (2 0 0 3) . Adherence to long term therapies: Evidence for action (pp.27-38), WHO Publications.

3 WH O : Wo r l d he a l t h s t a t i s t i c s 2 0 1 1 . http://www.who.int.whosis/wostat/2011

4 James K, In di a n de m o g r a p h i c ch a n g e : op p o r t u n i t i e s a n d ch a ll e n g e s . Science 2011, 333(6042):576-580.

5 Fe d e r a l Int e r a g e n c y Fo r u m on A g in g Re l a t e d St a t i s t i c s . Older Americans 2010: key indications of well-being. A v a i l a b l e f r o m http://www.agingstats.gov/chartbook2000/default.htm. A cc e s s M a r c h 4 , 2 01 2 .

6 Fe d e r a l Int e r a g e n c y Fo r u m on A g in g - r e l a t e d St a t i s t i c s . Older Americans update 2006: Key Indicators of well-being. Wash- ington, DC: US Government printing office: May 2006

7 Gurwitz JH. P o l y p h a r m a c y : A ne w p a r a d i g m fo r qu a li t y dr ug t h e r a p y in t h e el d e r s? Arch Intern Med. 2004;164:1957-1959.

8 Tinetti MD. Falls. In: Cassel CK, et al., eds. G e r i a t r i c m e di c i n e . 2d e d . New York: Springer-Verlag, 1990: 528–34.

9 Ce nt e r s fo r dis e a s e co nt r o l a n d pr e v e nt i o n . S e x u a l l y t r a n s - m i t t e d dis e a s e t r e a t m e nt gui d e l i n e s 2 0 0 2 . Section on clinical prevention guidelines. M M W R Recomm Rep 2002;51(RR-6):2-5.

1 0 R.N.Podell and L.R.Gary, “ C o m p l i a n c e : A pr o b l e m in me di c a l ma n a g e m e nt , ” Am Fam Physician 13(1976):74-80.

1 1 R.Brain Haynes, “ St r a t e g i e s t o imp r o v e co m p l i a n c e wit h re f e r r a l s , a p p o i nt- m e nt s , a n d Pr e s c r i b e d M e di c i n e r e g i m e n s , ” In Haynes, Compliance in healthcare.

1 2 Falvo,D.R (1994). Effe c t i v e p at i e nt e du c a t i o n . A gui d e t o in c r e a s e co m p l i a n c e . 2 ed., Aspen Publishers, Gaithersburg.

13 Howard J. Eng, Eun Sul Lee . T h e ro l e of pr e s c r i p t i o n dr ug s in he a l t h c a r e fo r t h e el d e r l y. J Health Hum Resour Adm 1987;9(3):306-318.

1 4 Helen Levens Lipton, and Philip R. Lee ‘ D r u g s a n d t h e Elde r l y : C lin i c a l , S o c i a l , a n d Po li c y Pe r s p e c t i v e s . INTL J of Te c h n o l o g y A s s e s s m e nt in H e a l t h C a r e 19 9 0 ; 6 ( 2 ) : 3 4 8 - 3 4 9 .

15 Lamy. Dr ug Use a n d t h e Elde r l y : S o m e ob s e r v a t i o n s a n d re c o m - m e n d a t i o n s . The Maryland Pharmacist 1988;68(3):10-15.

1 6 Michael C. Sokol , Kimberly A, McGuigan, Robert R, Verbrugge, Robert S.Epstein. 20 0 5 ; 4 3 ( 6 ) : 5 2 1 - 5 3 0 .

1 7 Wen Kwang Lim, Micheal C Woodwards. I m p r o v i n g m e di c a t i o n out c o m e in ol d e r p e o p l e . Aust J Hosp Pharm 1999;29(2):103-7.

1 8 Co m p e t i t i o n a n d co s t of ho s p i t a l c a r e , JAMA 1987;(258)15:2064-6.

19 Wendt DA. Evalu a t i o n of me di c a t i o n ma n a g e m e nt int e r v e nt i o n fo r t h e el d e r l y. H o m e H e a l t h c a r e Nur s e 19 9 8 ; 1 6 : 61 2 - 7.

2 0 Hamdy R, Moore SW, Whalen K, et al. R e d u c i n g p o l y p h a r m a c y in e x t e n d i n g c a r e . S o u t h M e d J 19 9 5 ; 8 8 : 5 3 4 - 8 .

2 1 Evans BB. A I DES to imp r o v e m e di c a t i o n a dh e r e n c e in ol d e r a dul t s . G e r i a t r Nur s 2 0 0 6 ; 2 7 ( 3) : 1 74 - 1 8 2 .

THE FUTURE O F PH A R M A C Y